Effectiveness of Withania somnifera (Ashwagandha) in prevention of Cancer: A Systematic Review
Abstract
Withania somnifera (Ashwagandha) helps prevent cancer through its strong antioxidant and anti-inflammatory properties. It boosts immune function by enhancing natural killer cells and macrophages. Withaferin A in ashwagandha promotes apoptosis in cancer cells without harming normal cells. It inhibits tumour growth by blocking angiogenesis and supports hormonal balance. Ashwagandha also aids DNA protection and repair, reducing cancer risk. The Objective of the study is to systematically evaluate the effectiveness of W. Somnifera in the prevention of cancer, based on evidence from clinical studies. A systematic review was conducted following PRISMA guidelines. Databases searched included PubMed, ScienceDirect, Wiley Online Library, and SpringerLink. Studies from 2001 to 2023 were screened using specific inclusion/exclusion criteria, focusing on W. somnifera effect on cancer-related outcomes. The risk of bias used tool is the Cochrane’s revised tool for randomized trials (RoB 2). The systematic review identified six eligible studies that demonstrated various anticancer effects of W. somnifera. This included inhibition of tumor growth, suppression of metastasis, enhancement of chemotherapy tolerance, and improved quality of life. The studies used different preparations of the herb, and the active compounds—particularly Withaferin A and withanone—were shown to induce apoptosis, regulate immune responses, and target cancer pathways effectively. Withania somnifera shows promising anticancer potential, acting through multiple pathways including antioxidant defense, hormonal regulation, and tumor suppression. While preclinical and early clinical findings are encouraging, more large-scale human trials are needed to establish its safety, efficacy, and clinical utility in cancer prevention and therapy.
Downloads
References
World Health Organization. World health statistics 2023: monitoring health for the SDGs, sustainable development goals. Geneva: World Health Organization; 2023. Available from: https://iris.who.int/handle/10665/367912
Aggarwal BB, Ichikawa H, Garodia P, Weerasinghe P, Sethi G, Bhatt ID, et al. From traditional Ayurvedic medicine to modern medicine: identification of therapeutic targets for suppression of inflammation and cancer. Expert Opin Ther Targets. 2006;10(1):87-118.
Bhat JA, Ahmad M, Dar NJ, Hussain A, Najar RA, Sharma S, et al. Abstract 1376: Novel HDAC inhibitor SBAK-GHA: Potential therapeutic molecule for lymphocytic leukaemia. Cancer Res. 2017; 77:1376.
Karati D, Kumar D. A Comprehensive Review on Targeted Cancer Therapy: New Face of Treatment Approach. Curr Pharm Des. 2023;29(41):3282-3294.
Uddin Q, Samiulla L, Singh V, Jamil S. Phytochemical and pharmacological profile of Withania somnifera dunal: a review. J Appl Pharm Sci. 2012;2(1):170-175.
Tewari D, Chander V, Dhyani A, Sahu S, Gupta P, Patni P, et al. Withania somnifera L. Dunal: Phytochemistry, structure-activity relationship, and anticancer potential. Phytomedicine. 2022;98:153949.
Rai M, Jogee PS, Agarkar G, Santos CA. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives. Pharm Biol. 2015;54(2):189-197.
Mirjalili M, Moyano E, Bonfill M, Cusido R, Palazón J. Steroidal lactones from Withania somnifera, an ancient plant for novel medicine. Molecules. 2009;14:2373-2393.
Rathi R, Tiwari A. Therapeutic potential of Withania somnifera in cancer treatment. Pharmacol Rev. 2021;15(30):56-66.
Farooqui AA, Farooqui T, Madan A, Ong JH, Ong WY. Ayurvedic Medicine for the Treatment of Dementia: Mechanistic Aspects. Evid Based Complement Alternat Med.2018:2481076.
Wadegaonkar VP, Wadegaonkar PA. Withanone as an inhibitor of survivin: a potential drug candidate for cancer therapy. J Biotechnol. 2013;168(2):229-233.
Subbaraju GV, Vanisree M, Rao CV, Sivaramakrishna C, Sridhar P, Jayaprakasam B, et al. Ashwagandhanolide, a bioactive dimeric thiowithanolide isolated from the roots of Withania somnifera. J Nat Prod. 2006; 69:1790-1792.
Alam N, Hossain M, Khalil MI, Moniruzzaman M, Sulaiman SA, Gan SH. High catechin concentrations detected in Withania somnifera ashwagandha by high performance liquid chromatography analysis. BMC Complement Altern Med. 2011; 11:65.
Gupta GL, Rana AC. Withania somnifera Ashwagandha: a review. Pharmacogn Rev. 2007; 1:129-136.
Gu M, Yu Y, Gunaherath GMKB, et al. Structure-activity relationship (SAR) of withanolides to inhibit Hsp90 for its activity in pancreatic cancer cells. Invest New Drugs. 2014; 32:68-74.
Kumar P, Sharma R, Garg N. Withania somnifera - a magic plant targeting multiple pathways in cancer related inflammation. Phytomedicine. 2022; 101:154137.
Rai M, Jogee PS, Agarkar G, Santos CA. Anticancer activities of Withania somnifera: Current research, formulations, and future perspectives. Pharm Biol. 2015;54(2):189-197.
Nejadghaderi SA, Balibegloo M, Rezaei N. The Cochrane risk of bias assessment tool 2 (RoB 2) versus the original RoB: A perspective on the pros and cons. Health Sci Rep. 2024;7(6): e2165.
Davis L, Kuttan G. Effect of Withania somnifera on DMBA induced carcinogenesis. J Ethnopharmacol. 2001;75(2-3):165-168.
Christina AJ, Joseph DG, Packialakshmi M, Kothai R, Robert SJ, Chidambaranathan N, et al. Anticarcinogenic activity of Withania somnifera Dunal against Dalton's ascitic lymphoma. J Ethnopharmacol. 2004;93(2-3):359-361.
Biswal BM, Sulaiman SA, Ismail HC, Zakaria H, Musa KI. Effect of Withania somnifera (Ashwagandha) on the development of chemotherapy-induced fatigue and quality of life in breast cancer patients. Integr Cancer Ther. 2013;12(4):312-322.
Hahm ER, Lee J, Kim SH, Sehrawat A, Arlotti JA, Shiva SS, et al. Metabolic alterations in mammary cancer prevention by withaferin A in a clinically relevant mouse model. J Natl Cancer Inst. 2013;105(15):1111-1122.
Govindappa PK, Gautam V, Tripathi SM, et al. Effect of Withania somnifera on gentamicin induced renal lesions in rats. Rev Bras Farmacogn. 2019; 29:234-240.
Lopresti AL, Smith SJ, Malvi H, Kodgule R. An investigation into the stress-relieving and pharmacological actions of an ashwagandha (Withania somnifera) extract: A randomized, double-blind, placebo-controlled study. Medicine (Baltimore). 2019;98(37): e17186.
Sreenu B, Sindhu R, Banujothi A, Lubna Fathima, Prabu D, Rajmohan M, et al. A systematic review of Aloe vera in chemotherapy & radiotherapy induced inflammation in cancer patients: unraveling the antiproliferative and proapoptotic effects on cancer. Cuest Fisioter. 2025;54(4):50-65.
Noor JJ, Sindhu R, Jothi AB, Prabhu D, Mohan MR, Dhamodhar D, et al. Modulatory effects of gingerol in cancer cell growth through activation and suppression of signal pathways in cancer cell growth: systematic review. J Pharm Boall Sci. 2024;16.
Lalthlamuanpuii, Fathima Lubna, Prabu, Manipal, Sunayana, Rajmohan, Bharathwaj. A systematic review on effectiveness of Aloe Vera in treating recurrent aphthous stomatitis. Journal of Pharmaceutical Sciences and Research.2019;11(9): 3223-3226.
Widodo N, Kaur K, Shrestha BG, Takagi Y, Ishii T, Wadhwa R, et al. Selective killing of cancer cells by leaf extract of Ashwagandha: identification of a tumor-inhibitory factor and the first molecular insights to its effect. Clin Cancer Res. 2007;13(7):2298-2306.
Elzayat EM, Elsamahy GE, Mansour GH, El-Sherif AA, Hassan N. The synergistic and anticancer potential of Withania somnifera (Ashwagandha) ethanol extract as an adjuvant with doxorubicin in MCF7 breast cancer cell line. Asian Pac J Cancer Prev. 2025;26(3):757-766.
